Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Metabolomic Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10480
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existing in the metabolome of a cell, tissue and organism. It provides research activities such as biobank that enables the development of predictive screening tests; and training to clinical academics, midwives, PhD students and postdoctoral fellows, among others. Metabolomic Diagnostics collaborates with universities and research institutions for the development and validation of its early pregnancy screening test for pre-eclampsia based on metabolomic biomarkers and clinical risk factors. The company operates in Ireland. Metabolomic Diagnostics is headquartered in Cork, Ireland.

Metabolomic Diagnostics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Metabolomic Diagnostics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 10
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 11
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 12
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 13
Metabolomic Diagnostics Secures Venture Funding from SOSventures 14
Partnerships 15
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 15
Metabolomic Diagnostics Ltd – Key Competitors 16
Metabolomic Diagnostics Ltd – Key Employees 17
Metabolomic Diagnostics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Metabolomic Diagnostics Ltd, Medical Equipment, Key Facts 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 8
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 10
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 11
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 12
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 13
Metabolomic Diagnostics Secures Venture Funding from SOSventures 14
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 15
Metabolomic Diagnostics Ltd, Key Competitors 16
Metabolomic Diagnostics Ltd, Key Employees 17
Metabolomic Diagnostics Ltd, Subsidiaries 18

List of Figures
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncor Electric Delivery Co LLC:企業の戦略的SWOT分析
    Oncor Electric Delivery Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kering SA:企業の戦略・SWOT・財務情報
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Deutsche Wohnen AG:企業のM&A・事業提携・投資動向
    Deutsche Wohnen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Wohnen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Exelon Corporation:企業のM&A・事業提携・投資動向
    Exelon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exelon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Servair:企業の戦略・SWOT・財務分析
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Invivo Corp:医療機器:M&Aディール及び事業提携情報
    Summary Invivo Corp (Invivo), a subsidiary of Koninklijke Philips NV is a medical device company that designs, manufactures, and markets patient monitoring systems. The company offers products in various categories such as advanced visualization systems, breast imaging and biopsy solutions, neuro im …
  • Velatia SL:企業の戦略的SWOT分析
    Velatia SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Kezar Life Sciences Inc (KZR):製薬・医療:M&Aディール及び事業提携情報
    Summary Kezar Life Sciences Inc (Kezar Life Sciences) is a clinical-stage biotechnology company that discovers and develops small molecule therapies to treat autoimmunity and cancer. The company’s lead product candidate, KZR-616, an immunoproteasome inhibitor intended for the treatment of various au …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • Synchronoss Technologies Inc (SNCR):企業の財務・戦略的SWOT分析
    Synchronoss Technologies Inc (SNCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Religare Enterprises Limited:企業のM&A・事業提携・投資動向
    Religare Enterprises Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Religare Enterprises Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Flowserve Corporation:企業の戦略・SWOT・財務分析
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vanderbilt University:製薬・医療:M&Aディール及び事業提携情報
    Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as c …
  • Kien Long Commercial Joint Stock Bank (KBC):企業の戦略的SWOT分析
    Kien Long Commercial Joint Stock Bank (KBC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Imagion Biosystems Inc:製品パイプライン分析
    Summary Imagion Biosystems Inc (Imagion Biosystems), formerly Senior Scientific LLC, a subsidiary of Manhattan Scientifics Inc, is a biomedical equipment provider that offers nanomagnetic particle detection systems. The company offers nanomagnetic relaxometry method for cancer detection and precisio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆